Next Article in Journal
The Optimization of Gel Preparations Using the Active Compounds of Arabica Coffee Ground Nanoparticles
Previous Article in Journal
4-Hydroxyderricin Isolated from the Sap of Angelica keiskei Koidzumi: Evaluation of Its Inhibitory Activity towards Dipeptidyl Peptidase-IV
Open AccessArticle

Stability Indicating HPLC-ECD Method for the Analysis of Clarithromycin in Pharmaceutical Dosage Forms: Method Scaling versus Re-Validation

Division of Pharmaceutics, Faculty of Pharmacy, Rhodes University, 6140 Grahamstown, South Africa
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2019, 87(4), 31; https://doi.org/10.3390/scipharm87040031
Received: 16 October 2019 / Revised: 4 November 2019 / Accepted: 6 November 2019 / Published: 16 November 2019
An isocratic high-performance liquid chromatographic method using electrochemical detection (HPLC-ECD) for the quantitation of clarithromycin (CLA) was developed using Response Surface Methodology (RSM) based on a Central Composite Design (CCD). The method was validated using International Conference on Harmonization (ICH) guidelines with an analytical run time of 20 min. Method re-validation following a change in analytical column was successful in reducing the analytical run time to 13 min, decreasing solvent consumption thus facilitating environmental and financial sustainability. The applicability of using the United States Pharmacopeia (USP) method scaling approach in place of method re-validation using a column with a different L–designation to the original analytical column, was investigated. The scaled method met all USP system suitability requirements for resolution, tailing factor and % relative standard deviation (RSD). The re-validated and scaled method was successfully used to resolve CLA from manufacturing excipients in commercially available dosage forms. Although USP method scaling is only permitted for columns within the same L-designation, these data suggest that it may also be applicable to columns of different designation. View Full-Text
Keywords: clarithromycin; electrochemical detection; central composite design; method validation; USP method scaling; stability-indicating clarithromycin; electrochemical detection; central composite design; method validation; USP method scaling; stability-indicating
Show Figures

Graphical abstract

MDPI and ACS Style

Makoni, P.A.; Chikukwa, M.T.R.; Khamanga, S.M.M.; Walker, R.B. Stability Indicating HPLC-ECD Method for the Analysis of Clarithromycin in Pharmaceutical Dosage Forms: Method Scaling versus Re-Validation. Sci. Pharm. 2019, 87, 31.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop